← Back to headlines
Serbia Signs Agreement with AstraZeneca for Innovative Oncology Drugs
The Serbian Health Insurance Fund (RFZO) and AstraZeneca have signed an agreement in Belgrade to include innovative oncology drugs on the RFZO list for cancer patients.
Sources
Showing 0 of 2 sources
No articles available in your preferred languages.
2 articles available in other languages below.
n1-serbiaCroatian3h ago
Potpisan ugovor RFZO i AstraZeneke o inovativnim lekovima za onkološke pacijente u Srbiji
U Beogradu je potpisan ugovor između Republičkog fonda za zdravstveno osiguranje i kompanije AstraZeneka po kom će se inovativni lekovi za onkološke p
Read full article →danasCroatian3h ago
Potpisan ugovor RFZO i kompanije AstraZeneka o inovativnim lekovima za onkološke pacijente u Srbiji
U Beogradu je danas potpisan ugovor između Republičkog fonda za zdravstveno osiguranje i kompanije AstraZeneka po kom će se inovativni lekovi za onkološke pacijente naći na listi RFZO.
Read full article →Coverage Timeline
First report: danas · 8 Apr, 11:28|Full coverage: 2 · 10m|Window: 10m
Left-leaningCenterRight-leaning
Related Stories
Manila Water prepares for summer heat and high demand
just now
Philippines Announces Results of April 2026 Physicians Licensure Examination
just now
Pagasa flags 2 areas for dangerous heat index levels on April 9
just now
Philippines Experiences High Heat Index, DOH Issues Warnings as Areas Log Danger Levels
just now